MedicineOncologyOral PathologyCarcinogenesisNeoplasiaOncogenesOral Cancer PathologyOral CarcinogenesisOral Cavity CancerOral NeoplasiaSquamous Cell CarcinomaImmediate Early Gene ExpressionMalignant Oral LesionsOral Cavity LesionsOral Cavity PathologyOral Epithelial CarcinogenesisOral Lesion Malignant TransformationPremalignant Oral Lesions
OBJECTIVES: Oral cancer is a worldwide phenomenon. It is thought to develop in a number of premalignant lesions. Protooncogene c fos is a known transformer of premalignant to malignant lesions. However, its role in oral carcinogenesis is not yet known. STUDY DESIGN: A total of 130 cases were studied comprising of premalignant lesions (n=50), squamous cell carcinoma (n=50) and controls (n=30). c fos expression was studied by immunohistochemistry. RESULTS: Premalignant lesions of oral cavity occurred at a lower age group (mean 39.2 years) compared to squamous cell carcinoma (mean 51.8 years), p <0.001. Mean c fos percentage positivity in squamous cell carcinomas (SCC), premalignant lesions and controls was 44.5+/-36.9%, 11.4+/-18.8% and 1.23+/-2.6% respectively, the differences were highly significant (p<0.001). c fos positivity also increased from mild (10.85+/-14.23%) to moderate dysplasia (19.64 +/-26.05%). CONCLUSIONS: The serially increasing c fos expression from normal mucosa to premalignant lesions to SCC and in dysplasias suggests that it could be an early gene to get activated and form transcription factor activator protein -1(AP-1).
18
c-fos is required for malignant progression of skin tumors
Enrique Sáez, Susan Rutberg, Elisabetta Mueller et al. · Cell · 1995 · 348 citations · Full text
Medicine, Cancer Biology, Oncology +13
Induction of fos RNA by DNA-damaging agents.
M. Christine Hollander, Albert J. Fornace · PubMed · 1989 · 204 citations